The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Pharma with 2,330 puts trading, or 1.1x expected. Most active are 2/14 weekly 36 puts and 2/28 weekly 36 puts, ...

Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The ...

A clear endorsement from their healthcare provider and being supplied information about recommended vaccines before their ...

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

Slaughter and May has elected David Johnson as its next managing partner, succeeding Deborah Finkler in the role. The change ...

Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

GSK posted a better-than-expected fourth quarter on Wednesday and lifted its 2031 sales target to nearly $50 billion as the British drugmaker aims to invest heavily in its specialty medicines to ...

Banco Santander topped Stoxx 600 gains, up 8.3%, after the Spanish lender reported record quarterly profit. Pharma giant GSK ...